Skip to main content
. Author manuscript; available in PMC: 2011 Jul 27.
Published in final edited form as: Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8829–8836. doi: 10.1158/1078-0432.CCR-05-1728

Fig. 3.

Fig. 3

Docetaxel treatment results in FAK cleavage. The taxane-sensitive (A) and taxane-resistant (B) SKOV3 cells were cultured in the presence of docetaxel for 48 or 72 hours. Western blot analysis for FAK in SKOV3 and SKOV3-TR cells in the presence or absence of the caspase-3 inhibitor DEVD-fmk.